Significantly,SCH58261 reversed the metabolically suppressive effect of adenosineto strengthen the efficacy of ICD by increasing the tumor infiltrationof CD8+ T lymphocytes and reducing the population of MDSCs.This nanomedicine inhibited not only primary and abscopal tumors butalso distant tumor metastases in 4T1 tumor-bearing mice. This evidence concerns the gene CD8A and neoplasm.